70 YEARS OF ACTIVITY For Cancer Patients

Israel Cancer Association // Annual Report 2022

Name of researcher

Institution

Research Subject

Funding received

Dr. Assaf Bester

Sheba Medical Center

Studying the potential of CYTOR lncRNA as a new therapeutic target for cancer The role of melanoma extracellular vesicles in the microenvironment cells’ immune-tolerance AI modeling for personalized nano technology-based phototherapy cancer treatment Unravel the diverse clinical course of Chimeric Antigen Receptor T cell therapy by quantifying the immune status 18F-fluorodihydrotestosterone (FDHT) PET/CT as a tool for assessment of treatment efficacy in breast cancer

Prof. Shoshana Greenberger Sheba Medical Center

Prof. Orit Shefi

Bar Ilan University

ICA-USA Board of Directors

Prof. Shai Shen-Orr

Technion

Dr. Marina Orevi

Hadass Ein Kerem Medical Center

Dr. Dalit Barkan

Haifa University Inhibiting Metastatic Outgrowth of Dormant Tumor Cells using Soluble Mediators of Resolution-Promoting Macrophages

Lynne & Howard Halpern

Prof. Diane Levin-Zamir Clalit Health Services Dr. Galit Hirsh-Yechezkel Sheba Medical Center

Evaluating the effectiveness of digital smoking cessation workshops

Cancer Incidence among beekeepers

Prof. Rabia, Asala

Hadass Ein Kerem Medical Center

Galectin-3 as a Mechanistic Biomarker for Cancer Progression After Acute Myocardial Infarction and Cardiac Remodeling

Daisy & Dr. John Merry

Early Detection Projects and Research Programs

symptoms. Better understanding of the effect of immunotherapy on the hypothalamic-pituitary adrenal axis my lead to an early detection and improved guidelines. • Prof. Zohar Levi , Rabin Medical Center – Artificial Intelligence successfully identifies subjects who are at high risk for colorectal cancer and will not show up for colonoscopy within six months following a positive fecal occult blood test.

The ICA encourages proposals for projects or researches in the area of early detection. In 2022, the Early Detection Committee, headed by Prof. L. Keinan-Boker , approved funding for projects by the following researchers: • Dr. Carmell Fink , Shamir Medical Center – Early detection of adrenal insufficiency in patients treated with immune checkpoint inhibitors regardless of

54